US Patent Issued to Vaxthera on July 7 for "Coronavirus vaccine comprising a mosaic protein" (Wisconsin Inventor)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,100, issued on July 7, was assigned to Vaxthera SAS (Medellin, Colombia).

"Coronavirus vaccine comprising a mosaic protein" was invented by Jorge E. Osorio (Mount Horeb, Wis.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are mosaic coronavirus (MoCoV) spike(S) proteins or antigenic fragments thereof. Also disclosed herein are nucleic acid constructs comprising one or more nucleic acid sequences encoding a MoCoV S protein or antigenic fragment thereof. Also disclosed herein are coronavirus vaccine vectors comprising one or more polynucleotides encoding a MoCoV S protein or antigenic fragment thereof. Also disclosed herein are coronav...